ISMP Medication Safety Alert!®

Community/Ambulatory

A valuable resource to reduce medication error risk in outpatient settings

The ISMP Medication Safety Alert!®Community/Ambulatory Care is a digital newsletter, published monthly for healthcare practitioners in ambulatory settings, including community pharmacies, specialty pharmacies, outpatient clinics, physician offices, and state institutions.

Who reads this newsletter?

  • Community/ambulatory/specialty care pharmacists
  • Pharmacy managers and executives
  • Pharmacy technicians and other pharmacy staff
  • Physicians and nurses in ambulatory practice
  • Anyone concerned with medication safety

Subscription Options

Online access to twelve (12) issues per year. Subscriptions start with the first issue after the date of purchase. You will receive a reminder notice via email to renew your annual subscription before your subscription expires. Your subscription will not automatically renew.
Access to back issues are not included. Single issues are available for purchase. 

Academic-based subscription: contact ISMP for pricing

Pharmaceutical Industry subscription: contact ISMP pricing


 

Personal Subscription

Subscription Information

  • $70.00 per year

  • Online access for one (1) user

  • No re-distribution is permitted

Single Site Subscription

Subscription Information for healthcare organizations

  • $100.00 per year

  • Online access for up to 50 users within a single site organization

  • Permission to re-distribute within single-site location 

  • Instructions to add users to a subscription will be emailed to the user purchasing the subscription

  • Please use your organization email address when subscribing

  • Multi-site organizations: Contact ISMP for pricing

Browse Issues

This month's main topic: Leadership Support is Vital: If We Fail to Support Caregivers, There Will Be Few Left to Support Care
This month's main topic: Patient Taking Hydroxychloroquine Right After Discontinuing Azithromycin Develops QTc Prolongation and Cardiac Arrest
This month's main topic: QuarterWatchTM (includes new data from Quarter 2, 2019): Preventable Methotrexate Errors and Trends Among Addictive Drugs
This month's main topic: QuarterWatchTM (includes new data from Quarter 4, 2018 and Quarter 1, 2019): Focus on Four New Drugs: Xofluza, Aimovig, Ajovy, and Emgality